newsfilter
← Latest News
ClinicalTrials.gov·

A Study of Single and Multiple Doses of ALXN1210 in Healthy, Adult Japanese Participants - NCT05288816

Incidence Of Treatment-Emergent Adverse Events, Incidence Of Anti-Drug Antibodies (ADAs) To ALXN1210, Area Under The Concentration-Time Curve From Time Zero To Infinity (AUCinf) For Single And Multiple Doses Of ALXN1210, (and 4 more...)